What is NMAD's dilution risk score?

NMAD has a latest available DilutionScore record of 68/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for NMAD, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for NMAD?

DilutionWatch tracks 25 SEC filing types for NMAD including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect NMAD shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For NMAD, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for NMAD tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for NMAD. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

NMAD Dilution Risk Score: 68/100

Score Breakdown

📋 Offering Ability

💰 Cash Runway

📊Float Risk—

⚠️ Warrant Exposure

🔄 Convertible Debt

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 26%

📜 Warrant Exercise model 40%

• Significant warrants: 22% of shares outstanding

• Elevated warrant risk score (70/100)

💰 Capital Raise model 15%

• Under 12 months cash (9mo)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (68/100)

🔔 Track NMAD — Get forecast alerts →

Market Data

Market Cap$68.11M

Shares Outstanding16.10M

FloatN/A

Cash$3.41M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	68/100	DilutionWatch score record
Shares Outstanding	16.10M	Verified float table or market cache
Public Float	Not available	Verified float table or market cache
Market Cap	$68.11M	Market data cache
Cash Runway	9.2 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	3.61M	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest1.02M

Days to Cover5.1

% of FloatN/A

FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-14

xbrl XBRL WARRANT 2026-08-14

8-K 8K EVENT 2026-06-16

Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NMAD Dilution Snapshot

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) has a DilutionScore of 68/100, rated High dilution risk. Score date: October 13, 2026.

Stored outstanding warrants: 3.6M.
Recent SEC activity tracked for NMAD: xbrl on 2026-08-14; xbrl on 2026-08-14; 8-K on 2026-06-16.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NMAD's DilutionScore is currently 68/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 58/100 (High risk).

Period	Score	Risk Level	Duration
Sep 28 – Oct 13, 2026	68/100	HIGH	16 days
Aug 22 – Sep 27, 2026	58/100	HIGH	37 days
Aug 14 – Aug 21, 2026	56/100	HIGH	7 days
Jul 16 – Aug 13, 2026	52/100	HIGH	29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track NMAD Dilution Risk in Real-Time

DilutionWatch monitors SEC filings 24/7 and alerts you the moment NMAD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.

Start Tracking NMAD — Free

Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

NMAD — LIXTE BIOTECHNOLOGY HOLDINGS, INC. Dilution Risk Tracker